Stempoint Capital LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Stempoint Capital LP
CRD #324248
SEC #801-127041
CIK #0001952142
AUM 761.3 M (2026-03-30)
Employees 7 (57% Investors, 0% Brokers)
Fees
Minimum
Phone212-540-4099
Address520 Madison Avenue
New York, NY 10022
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
80064048032016002010201520212027
In the News
Thu, 30 Jul 2026 Stempoint Capital LP Takes $1.23 Million Position in LB Pharmaceuticals Inc $LBRX — MarketBeat
Thu, 30 Jul 2026 Stempoint Capital LP Has $34.94 Million Stock Position in Abivax SA Sponsored ADR $ABVX — MarketBeat
Thu, 30 Jul 2026 Stempoint Capital LP Acquires New Holdings in Biodesix, Inc. $BDSX — MarketBeat
Thu, 30 Jul 2026 Stempoint Capital LP Makes New $4.89 Million Investment in Nurix Therapeutics, Inc. $NRIX — MarketBeat
Thu, 30 Jul 2026 Stempoint Capital LP Buys 125,581 Shares of Evommune, Inc. $EVMN — MarketBeat
Sector Form 13F Holdings Value ($M)
Scholar Rock Holding Corp 111.6
Revolution Medicines Inc 74.2
Abivax Sa 69.9
Syndax Pharmaceuticals Inc 63.8
Health Sciences Acquisitions Corp 42.1
Praxis Precision Medicines Inc 36.3
Boston Scientific Corp 31.4
MBX Biosciences Inc 29.8
Mineralys Therapeutics Inc 28.9
Imara Inc 28.5
View All
Holdings by Sector ($M)
1300104078052026002024202520262027
Type Form D Funds Date Sold AUM
HF Stempoint Capital Opportunity Master Fund LP [2025-03-28] 75.7 M 137.0 M
Filed 2025-10-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $500,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Stempoint Capital Master Fund LP [2023-02-02] 72.4 M 447.4 M
Filed 2025-10-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 7 645.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 116.3
(n) Other 0 0.0
Total 8 761.3
By Discretionary
Discretionary 8 761.3
Non-Discretionary 0 0.0
Total 8 761.3
By Non-United States Persons
Non-United States Persons 645.0
United States Persons 116.3
Total 8 761.3
Form D Directors Role # Filings # Firms 2011 - 2026
Robert Duggan Director 29 7
Miles Perryman Director 8 4
Sean Tan Director 9 2
Stempoint Capital LP Promoter 4 2
EDGAR Form CIK 2011 - 2026
13F-HR [0001952142]
SC 13G [0001952142]
Form 13D/13G Filer Form 13D/13G Subject Filed
Stempoint Capital LP Sensei Biotherapeutics Inc [2026-05-15]
Stempoint Capital LP Xilio Therapeutics Inc [2025-11-14]
Stempoint Capital LP Surrozen Inc/DE [2024-11-01]
Stempoint Capital LP Vistagen Therapeutics Inc [2024-02-12]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund
LEI549300SQHSDQCTFLCL20
Comparable Firms State AUM
Benchmark Plus Management LLC
WA 767.4 M
Coinfund Management LLC
NY 766.0 M
Orange Investment Advisors LLC
FL 765.0 M
Lepercq de Neuflize Asset Management LLC
NY 763.7 M
Stonecastle Advisors LLC
NY 763.4 M
Sciencast Management LP
NJ 760.0 M
Shrewsbury River Capital LP
NJ 757.5 M
Riva Ridge Capital Management LP
NY 757.5 M
Mill Hill Capital LLC
NY 757.2 M
Alight Capital Management LP
NY 754.4 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com